Phytosterol

Better Health with Budget-friendly Peanuts

Retrieved on: 
星期二, 一月 24, 2023
Dementia, Phytosterol, Soil, Lunch, Systematic review, Fruit salad, JAMA Internal Medicine, PMID, Arginine, Niacin, Skin, UNESCO, Cancer, Snack, Water, PubMed, Stomach, PubMed Central, Pinterest, CO2, Ageing, Breast, British Journal of Nutrition, Alzheimer's disease, Egg, Meal, Research, Brain, Consumer, UNESCO Institute for Lifelong Learning, Colon, Cheese, Food industry, Antioxidant, Nitrogen, Breakfast, Overalls, Risk, Vitamin, Family, Anxiety, Mineral, Mortality, Meta-analysis, Depression, Multimedia, Journal of Neurology, Neurosurgery, and Psychiatry, Immune system, Legume, Dietary supplement, Vegetable oil

According to The Peanut Institute , peanuts and peanut butter are some of the most affordable, nutrient-dense sources of protein available.

Key Points: 
  • According to The Peanut Institute , peanuts and peanut butter are some of the most affordable, nutrient-dense sources of protein available.
  • Peanuts also contain arginine, which is an amino acid associated with higher growth velocity.2
    Healthy weight management in adults by delivering greater hunger satisfaction.
  • Niacin in particular is associated with a reduced rate of cognitive decline.4
    While the health benefits for peanuts stack up, they're also earth friendly.
  • Peanuts require less water than tree nuts.5 Compared to almonds, peanuts need less than half the water to grow.

Pure Gold: Kensing Receives Gold EcoVadis Sustainability Rating for 2023

Retrieved on: 
星期四, 一月 19, 2023
Phytosterol, Vitamin E, Gold, Growth, Recycling, Logan Kensing

KANKAKEE, Ill., Jan. 19, 2023 /PRNewswire/ -- Kensing, a world leader in plant-based vitamin E and phytosterols, and a U.S. leader in high-purity anionic and amphoteric surfactants, earned a Gold medal in the EcoVadis Sustainability Ratings for 2023.

Key Points: 
  • KANKAKEE, Ill., Jan. 19, 2023 /PRNewswire/ -- Kensing, a world leader in plant-based vitamin E and phytosterols, and a U.S. leader in high-purity anionic and amphoteric surfactants, earned a Gold medal in the EcoVadis Sustainability Ratings for 2023.
  • EcoVadis has provided one of the world's most trusted business sustainability ratings since 2007.
  • The Gold EcoVadis Sustainability Rating is, quite literally, the gold standard for the industry and places Kensing in the top 5 percentile.
  • "We are extremely proud to receive a gold rating in our very first submission," said Kensing CEO Serge Rogasik.

At Gulfood Manufacturing in Dubai, Concepta Ingredients presents Brazilian biodiversity portfolio

Retrieved on: 
星期二, 十一月 1, 2022
Brown sugar, Forest, Functional food, Sodium, Mineral, Knowledge, Phytosterol, Color, Water, Syagrus coronata, Istanbul Technical University Control and Automation Student Society, Butter, Research, Industry, Commercial, TVS Supply Chain Solutions, Muscovado, Group, Brazil nut cake, Technology, Oil, Arboreto di Arco, Food, History, Concepta Riley, Cerrado, Control, Safflower, Biodiversity, Brazil nut, Seed, Milk, Amazon, Solution, Automation, Vegetable oil, Agriculture, Renewable energy, Coffee, Helianthus, Caatinga, Sesame, Cold

"Concepta actively participates in several fairs, and this is an important opportunity to establish new connections and relationships, besides showing the work we develop with Brazilian ingredients", he pointed out.

Key Points: 
  • "Concepta actively participates in several fairs, and this is an important opportunity to establish new connections and relationships, besides showing the work we develop with Brazilian ingredients", he pointed out.
  • At Gulfood Manufacturing, we want to position ourselves with the presentation of Concepta Ingredients' most important products, always reinforcing the appreciation of Brazilian biodiversity inputs and the work built over the years by the company", she concluded.
  • During the fair, Concepta Ingredients also presents the Bio Abundance Program, launched in 2022, which reinforces the commitment to Brazilian forests.
  • Its complete portfolio has technological inputs from international partners and ingredients from biodiversity to meet the most specific demands of the industries in where it is present.

The Worldwide Lipid Nutrition Industry is Expected to Reach $17.5 Billion by 2031 - ResearchAndMarkets.com

Retrieved on: 
星期三, 九月 28, 2022
Fitness & Nutrition, Health, Projection, COVID-19, Eicosapentaenoic acid, MCT, Food, Nutrition, Cosmetics, Foodservice, Dietary supplement, Phytosterol, Personal care, Classification, Acid, Speciality chemicals, Pharmaceutical industry, Vegetable oil, Powder, Application, Form

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict.

Key Points: 
  • The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict.
  • The balanced (most likely) projection is used to quantify global lipid nutrition market in every aspect of the classification from perspectives of by Product, Source, Form, Application, Distribution, and Region.
  • Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
  • By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

onTop cosmetics is first Chinese beauty brand to launch sustainable cosmetic packaging made with Eastman Cristal™ Renew copolyester

Retrieved on: 
星期四, 七月 21, 2022
Cream, Carbon, Phytosterol, Beauty, WWP, Cosmetics, Skin, Industry, Lipid, Solution, Cristal, Skin care, ISCC, Technology, Heart, Life, International Sustainability Alliance, Light, Attitude, Organic acid, Recycling

KINGSPORT, Tenn., July 21, 2022 /PRNewswire/ -- onTop cosmetics has launched its Renewal Oil Cream, the first of its four core facial cream products to feature packaging made from Eastman Cristal™ Renew copolyester with 50% certified recycled content.* onTop cosmetics is the first Chinese beauty brand to use Cristal Renew, a sustainable resin powered by Eastman's molecular recycling technologies. This industry-leading skin care packaging is the result of the close collaboration between onTop's value chain partners — WWP Beauty and molecular recycling pioneer Eastman.

Key Points: 
  • * onTop cosmetics is the first Chinese beauty brand to use Cristal Renew, a sustainable resin powered by Eastman's molecular recycling technologies.
  • "onTop strives for light packaging, which is part of the attitude toward sustainability," said Emma Ni, onTop CEO.
  • Based on this mission, we chose to make sustainable packaging out of Eastman Cristal Renew for our newly launched cream product.
  • More information on Cristal Renew and Eastman's sustainable solutions for cosmetic packaging can be found at eastman.com/cristal .

A Daily Serving of Strawberries May Improve Cholesterol, Study Shows

Retrieved on: 
星期二, 七月 19, 2022
Research, Lafayette College, University, Cardiovascular disease, Phytosterol, News, Woman, Polyphenol, Carbohydrate, LDL, Inflammation, GLOBE, Texas Tech University, California Strawberry Commission, Overweight, Oxidative stress, Workforce, Pennsylvania State University, Potassium, Farm, Ageing, Health, Farmer, TC, Journal, Diet, Education, Man, Conditional sentence, Vaccine, Food preservation

The new study strengthens the body of research that has already demonstrated a cholesterol-lowering benefit from eating strawberries.

Key Points: 
  • The new study strengthens the body of research that has already demonstrated a cholesterol-lowering benefit from eating strawberries.
  • The study was conducted with 40 men and women, aged 35 to 60.
  • Other studies have previously linked strawberries, which are a source of fibre, phytosterols, and polyphenols, to several markers for cardiovascular disease.
  • The Pennsylvania State University led the study in cooperation with the University of Arizona, Tucson; Lafayette College; and Texas Tech University.

Valbiotis Announces the Positive Results of Its Clinical Study on the Bioavailability and Mode of Action of TOTUM•070, Against Hypercholesterolemia

Retrieved on: 
星期二, 三月 29, 2022
Cardiology, Biotechnology, Other Health, Health, General Health, Pharmaceutical, Other Science, Research, Fitness & Nutrition, Science, Clinical Trials, Company, Cholesterol, Cell, Risk, Metabolism, European Regional Development Fund, Human, Phytosterol, Industrial Affairs Committee (Iceland), Marketing, Trial of the century, Degenerative disease, Toxicity, Board, Translational research, BPI, Phase, Liver, Hepatocyte, Fibrinogen, Serum, Research, Investor, Teaching hospital, Phase II, ERDF, Hypercholesterolemia, Metabolomics, Red blood cell, Discovery, Director, Lists of diseases, AMF, Union, Development, De novo, Blood, Research and development, HEART, Volunteering, Pharmaceutical industry, Dietary supplement, Vaccine

The analyses were conducted following oral administration of the clinical dose of 5g of TOTUM070, used also in the Phase II HEART study.

Key Points: 
  • The analyses were conducted following oral administration of the clinical dose of 5g of TOTUM070, used also in the Phase II HEART study.
  • Following on from these positive results, Valbiotis will announce the outcome of its Phase II HEART clinical efficacy study in the second quarter of 2022, as planned.
  • These novel clinical data build on the positive preclinical results presented in 2021 and pave the way for further mode-of-action investigations in the liver.
  • Above all, they confirm the potential of TOTUM070 against hypercholesterolemia in humans, pending the imminent results of our Phase II clinical efficacy study.

Elicit Plant Raises €16M to Accelerate R&D and Marketing of Its Natural Solution Dedicated to the Reduction of Water Consumption by Plants in Agriculture

Retrieved on: 
星期一, 二月 7, 2022
Chemicals, Plastics, Manufacturing, Other Health, Technology, Other Natural Resources, Environment, Agriculture, Natural Resources, Other Technology, Other Manufacturing, Science, Biotechnology, Other Science, Health, Research, Sofinnova, Phytosterol, Agriculture, Growth, Multimedia, Solution, Labs, Heart, Technology, Metabolism, Farmer, Agtech, Climate change, Laboratory, Water, Partnership, Renewable energy, Fine chemical, Plant

The firms proprietary technology platform brings a breakthrough solution in the water stress resistance market, which is part of the 4 Bn global market of biostimulants.

Key Points: 
  • The firms proprietary technology platform brings a breakthrough solution in the water stress resistance market, which is part of the 4 Bn global market of biostimulants.
  • The solution naturally boosts plants metabolism, reducing their need for water and allowing for a better resistance to water stress.
  • Positive impact on water stress reduction was validated by a network of independent French and international researchers and farmers.
  • Elicit Plants proprietary technology is delivered through foliar application of phytosterols, a molecule found in plants that reduces water consumption by plants.

Valbiotis Announces Positive Preclinical Results for TOTUM•070 in Hypercholesterolemia, Selected and Presented at the American Heart Association (AHA) Annual Meeting

Retrieved on: 
星期一, 十一月 15, 2021
Biotechnology, Health, Fitness & Nutrition, Pharmaceutical, Clinical Trials, Phase II, Population, Volunteering, Lists of diseases, University, Atherosclerosis, AHA, PEA, LDL, Puy, Translational research, American Heart Association, Congress, European Union, HEART, Hypercholesterolemia, Liver, Investor, ERDF, Union, BPI, Multimedia, Research, AMF, Pharmacotherapy, Apolipoprotein B, Public Health Nutrition, Research and development, Company, Development, VLDL, European Regional Development Fund, Cholesterol, Phytosterol, Assistant, Risk, Lipid, Lipid metabolism, Pharmaceutical industry, Dietary supplement

Valbiotis is presenting two posters on TOTUM070 at the AHA meeting, which is being held November 13-15, 2021, in virtual format.

Key Points: 
  • Valbiotis is presenting two posters on TOTUM070 at the AHA meeting, which is being held November 13-15, 2021, in virtual format.
  • Recruitment has been completed and results are expected in the second quarter of 2022, with LDL cholesterol reduction as the primary endpoint.
  • Pascal SIRVENT, Director of Discovery, Preclinical and Translational Research, member of the Valbiotis Board of Directors, comments: "These results on TOTUM070 are striking in their consistency.
  • Valbiotis considers that these projections are based on rational hypotheses and the information available to Valbiotis at the present time.

Valbiotis Announces the Completion of Recruitment for the Phase II HEART Clinical Study Conducted With TOTUM•070 in Hypercholesterolemia, a Risk Factor for Cardiovascular Disease

Retrieved on: 
星期一, 九月 6, 2021
Research, Fitness & Nutrition, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, Other Science, Science, Lipids, Medical specialties, Branches of biology, Sterols, Cardiology, Lipoproteins, Lipid metabolism disorders, Low-density lipoprotein, Hypercholesterolemia, Cholesterol, Lipid-lowering agent, Phytosterol

In line with its development plan, Valbiotis confirms that the results of the HEART study will be available in the second quarter of 2022.

Key Points: 
  • In line with its development plan, Valbiotis confirms that the results of the HEART study will be available in the second quarter of 2022.
  • The HEART clinical study is a multicenter, international, randomized, placebo-controlled, double-blind study involving 120 people with untreated moderate hypercholesterolemia between 130 and 190 mg/dL.
  • The primary endpoint of the HEART study is the reduction of blood LDL-cholesterol levels, a risk factor for cardiovascular disease and in particular atherosclerosis, and it has several secondary objectives of interest.
  • The medical need is real: according to the WHO, nearly 40% of the world's adult population has high cholesterol, a well-known cardiovascular risk factor.